Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.92% | 286.02 | 0.0% | $3988.07m | |
| BNTX | BioNTech SE | 1.39% | 295.99 | 0.0% | $1278.94m | |
| NVAX | Novavax, Inc. | 4.81% | 190.50 | 78.2% | $906.19m | |
| AMGN | Amgen, Inc. | 0.07% | 213.68 | 1.4% | $652.04m | |
| LGVN | Longeveron Inc. | 0.09% | 21.92 | 0.0% | $515.78m | |
| GILD | Gilead Sciences, Inc. | -0.19% | 69.58 | 1.0% | $514.17m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.09% | 206.80 | 1.9% | $454.51m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 654.04 | 2.7% | $419.38m | |
| ILMN | Illumina, Inc. | -0.05% | 375.81 | 3.3% | $351.61m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 4.36 | 0.7% | $304.78m | |
| BIIB | Biogen, Inc. | -0.01% | 234.70 | 1.8% | $297.94m | |
| SGEN | Seagen Inc. | 0.00% | 149.55 | 5.8% | $157.99m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 86.26 | 18.0% | $150.95m | |
| INCY | Incyte Corp. | 0.00% | 67.33 | 2.4% | $147.13m | |
| TXG | 10X Genomics, Inc. | 2.17% | 155.41 | 0.0% | $140.47m |
Company Profile
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.